EP. 1: Optimal Multidisciplinary (MDT) Approach for the Management of NSCLC
A panel of experts review what an effective multidisciplinary approach for NSCLC management looks like and subspecialties included in multidisciplinary teams.
EP. 2: Decisions and Challenges in Multidisciplinary Teams
Experts examine decision-makers in treatment selection and navigate challenges in organizing multidisciplinary team meetings, from institutional to wider practice perspectives.
EP. 3: Enhancing NSCLC Management: MDT Approaches and Decisions
Experts explore strategies to increase the number of patients benefiting from multidisciplinary team (MDT) collaboration and the factors MDTs consider when deciding between surgical resection and nonsurgical options for early-stage NSCLC.
EP. 4: Assessing Pathological Responses in Patients With NSCLC
Specialists examine techniques for assessing pathological complete responses and various methods for response measurement in patients with NSCLC.
EP. 5: Early-Stage NSCLC Standard Treatments
Experts discuss the current standard treatment options for patients diagnosed with early-stage NSCLC [non-small cell lung cancer].
EP. 6: Immunotherapy in Surgical and Radiation Patients With NSCLC
Experts review their considerations when adding immunotherapy to both surgical patients and radiation patients with NSCLC.
EP. 7: Neoadjuvant Therapy in Early NSCLC Treatment
A panel discusses the role of neoadjuvant therapy in the current treatment approach for early stages of NSCLC.
EP. 8: Chemoimmunotherapy Timing: Pre or Post Surgery for Patients With NSCLC
Experts deliberate on the optimal timing of chemoimmunotherapy and if it should be before or after surgery.
EP. 9: Enhancing NSCLC Neoadjuvant Therapy
A panel deliberates post-neoadjuvant strategies and data requirements for optimizing immune checkpoint inhibitors in NSCLC neoadjuvant therapy.
EP. 10: Expert Forecasts in the Perioperative Landscape for NSCLC Patients
Experts discuss changes they foresee in the perioperative approach landscape for patients with NSCLC.
EP. 11: Metastatic NSCLC (mNSCLC) Biomarkers and Prognostic Factors Compared to Early-Stage NSCLC
Specialists review specific prognostic factors and biomarkers that help guide treatment selection for patients with metastatic NSCLC (mNSCLC) and discuss if these biomarkers differ from those observed in early-stage NSCLC.
EP. 12: Current Standard Treatments for mNSCLC
Experts discuss the current standard treatment options for patients diagnosed with metastatic NSCLC (mNSCLC).
EP. 13: Striking a Balance: Treatment vs Quality of Life for Patients With NSCLC
Panelists discuss balancing aggressive treatment strategies and maintaining the patient’s quality of life.
EP. 14: Pros and Cons of Immunotherapy in Metastatic NSCLC
Specialists assess the pros and cons of using immunotherapy in managing metastatic non–small cell lung cancer and delve into dosage variations and considerations when choosing different immunotherapy types.
EP. 15: Impact on Outcomes of Unmet Needs in NSCLC Treatment
Specialists discuss unmet needs that continue to exist in treating patients with NSCLC despite advances in treatment, and how these impact patient outcomes.
EP. 16: Expert Insights into NSCLC Unmet Needs
Experts offer concluding insights on unmet needs in NSCLC treatment and the future of patient care.
2 Clarke Drive Cranbury, NJ 08512